` INGN (Inogen Inc) vs S&P 500 Comparison - Alpha Spread

INGN
vs
S&P 500

Over the past 12 months, INGN has underperformed S&P 500, delivering a return of -16% compared to the S&P 500's 10% growth.

Stocks Performance
INGN vs S&P 500

Loading
INGN
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
INGN vs S&P 500

Loading
INGN
S&P 500
Difference
www.alphaspread.com

Performance By Year
INGN vs S&P 500

Loading
INGN
S&P 500
Add Stock

Competitors Performance
Inogen Inc vs Peers

Inogen Inc
Glance View

Market Cap
178.5m USD
Industry
Health Care

Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 1,021 full-time employees. The company went IPO on 2014-02-14. The firm primarily develops, manufactures, and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen with a single battery and can be plugged into a power outlet as needed. All of its Inogen One systems are equipped with Intelligent Delivery Technology, a form of pulse-dose technology, from which the patient receives a bolus of oxygen upon inhalation. The company has also launched Inogen Connect, a wireless connectivity platform for the Inogen One G4 and Inogen One G5 (portable oxygen concentrators) consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers.

INGN Intrinsic Value
11.92 USD
Undervaluation 44%
Intrinsic Value
Price
Back to Top